Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP379699.RAa78P3dnd68ZtmeuQ2kVd_vntsWJy9rz7vpVnj0nqFsM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP379699.RAa78P3dnd68ZtmeuQ2kVd_vntsWJy9rz7vpVnj0nqFsM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP379699.RAa78P3dnd68ZtmeuQ2kVd_vntsWJy9rz7vpVnj0nqFsM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP379699.RAa78P3dnd68ZtmeuQ2kVd_vntsWJy9rz7vpVnj0nqFsM130_provenance.
- NP379699.RAa78P3dnd68ZtmeuQ2kVd_vntsWJy9rz7vpVnj0nqFsM130_assertion description "[Irrespective of protein overexpression, HER-2/neu gene amplification is rare in lung cancer and studies on its prevalence and clinicopathological implications in early stage non-small cell lung cancer (NCSLC) and neuroendocrine tumours (NET) of the lung are lacking.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP379699.RAa78P3dnd68ZtmeuQ2kVd_vntsWJy9rz7vpVnj0nqFsM130_provenance.
- NP379699.RAa78P3dnd68ZtmeuQ2kVd_vntsWJy9rz7vpVnj0nqFsM130_assertion evidence source_evidence_literature NP379699.RAa78P3dnd68ZtmeuQ2kVd_vntsWJy9rz7vpVnj0nqFsM130_provenance.
- NP379699.RAa78P3dnd68ZtmeuQ2kVd_vntsWJy9rz7vpVnj0nqFsM130_assertion SIO_000772 15386424 NP379699.RAa78P3dnd68ZtmeuQ2kVd_vntsWJy9rz7vpVnj0nqFsM130_provenance.
- NP379699.RAa78P3dnd68ZtmeuQ2kVd_vntsWJy9rz7vpVnj0nqFsM130_assertion wasDerivedFrom befree-20150227 NP379699.RAa78P3dnd68ZtmeuQ2kVd_vntsWJy9rz7vpVnj0nqFsM130_provenance.
- NP379699.RAa78P3dnd68ZtmeuQ2kVd_vntsWJy9rz7vpVnj0nqFsM130_assertion wasGeneratedBy ECO_0000203 NP379699.RAa78P3dnd68ZtmeuQ2kVd_vntsWJy9rz7vpVnj0nqFsM130_provenance.
- befree-20150227 importedOn "2015-02-27" NP379699.RAa78P3dnd68ZtmeuQ2kVd_vntsWJy9rz7vpVnj0nqFsM130_provenance.